Drug factory · FDA FEI 3004537783

InfoRLife SA

Casai, Campascio, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, May 3, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2011: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AcetaminophenMakes it WG Critical Care, LLC. 44567-340
Calcium CationMakes it WG Critical Care, LLC. 44567-620, 44567-621, 44567-622 +1
DiltiazemMakes it, tests it, packages it and labels it WG Critical Care, LLC. 44567-662, 44567-663
EdaravoneMakes it Sandoz Inc. 0781-3527
LevofloxacinMakes it WG Critical Care, LLC. 44567-435, 44567-436, 44567-437
Magnesium CationMakes it WG Critical Care, LLC. 44567-170, 44567-410, 44567-420 +4
MetronidazoleMakes it WG Critical Care, LLC. 44567-750
MidazolamMakes it WG Critical Care, LLC. 44567-610, 44567-611
NorepinephrineMakes it WG Critical Care, LLC. 44567-640, 44567-641, 44567-642 +1

FDA inspection history

EndedResultProgramProblems noted
May 3, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 10, 2019No problems foundDrug Quality Assurance—
Feb 23, 2018No problems foundDrug Quality Assurance—
Aug 16, 2016No problems foundDrug Quality Assurance—
Jul 4, 2013No problems foundDrug Quality Assurance—
Apr 5, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack; sterilize.